Quaker Chemical Corp. (KWR) Sets New 52-Week High at $102.64
Shares of Quaker Chemical Corp. (NYSE:KWR) reached a new 52-week high on Monday . The stock traded as high as $102.64 and last traded at $100.79, with a volume of 134,204 shares trading hands. The stock had previously closed at $97.97.
KWR has been the subject of several research analyst reports. Zacks Investment Research lowered shares of Quaker Chemical Corp. from a “buy” rating to a “hold” rating in a research note on Thursday, July 7th. Seaport Global Securities lowered shares of Quaker Chemical Corp. from an “accumulate” rating to a “neutral” rating and set a $94.00 price objective for the company. in a research note on Monday, May 2nd. Finally, Jefferies Group reiterated a “hold” rating on shares of Quaker Chemical Corp. in a research note on Sunday, July 17th.
The firm has a market capitalization of $1.34 billion and a price-to-earnings ratio of 24.95. The company’s 50 day moving average price is $96.65 and its 200 day moving average price is $87.58.
Quaker Chemical Corp. (NYSE:KWR) last issued its quarterly earnings results on Wednesday, July 27th. The company reported $1.11 EPS for the quarter, beating analysts’ consensus estimates of $1.09 by $0.02. During the same quarter in the previous year, the business earned $1.15 earnings per share. The business had revenue of $186.91 million for the quarter, compared to the consensus estimate of $187.77 million. The firm’s revenue was up 1.7% on a year-over-year basis. Equities research analysts forecast that Quaker Chemical Corp. will post $4.56 earnings per share for the current fiscal year.
Quaker Chemical Corporation is engaged in providing process fluids, chemical specialties and technical expertise to a range of industries, including steel, aluminum, automotive, mining, aerospace, tube and pipe, cans and others. The Company operates through four segments: North America, the Europe; Middle East and Africa (EMEA); Asia/Pacific, and South America.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.